These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4054941)

  • 1. Biosynthesis of the third (C3), eighth (C8), and ninth (C9) complement components by guinea pig hepatocyte primary cultures.
    Ramadori G; Tedesco F; Bitter-Suermann D; Meyer zum Büschenfelde KH
    Immunobiology; 1985 Sep; 170(3):203-10. PubMed ID: 4054941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human umbilical vein endothelial cells synthesize functional C3, C5, C6, C8 and C9 in vitro.
    Johnson E; Hetland G
    Scand J Immunol; 1991 Jun; 33(6):667-71. PubMed ID: 2047760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional active complement components secreted by guinea pig peritoneal macrophages.
    Brade V; Kreuzpaintner G
    Immunobiology; 1982 Apr; 161(3-4):315-21. PubMed ID: 7047377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of immune haemolysis by a serum factor found in C3-deficient subjects.
    Kitamura H; Tsuboi M
    Immunology; 1989 Feb; 66(2):264-9. PubMed ID: 2925225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative determination of complement components produced by purified hepatocytes.
    Ramadori G; Rasokat H; Burger R; Meyer Zum Büschenfelde KH; Bitter-Suermann D
    Clin Exp Immunol; 1984 Jan; 55(1):189-96. PubMed ID: 6692595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the fifth and sixth component of the complement system: similarities between C5b6 and C(56)a with respect to lytic enhancement by cell-bound C3b or A2C, and species preferences of target cell.
    Hänsch GM; Hammer CH; Mayer MM; Shin ML
    J Immunol; 1981 Sep; 127(3):999-1002. PubMed ID: 6911149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biosynthesis of complement.
    Colten HR
    Adv Immunol; 1976; 22():67-118. PubMed ID: 769502
    [No Abstract]   [Full Text] [Related]  

  • 8. Secretion of the terminal complement proteins, C5-C9, by human platelets.
    Houle JJ; Leddy JP; Rosenfeld SI
    Clin Immunol Immunopathol; 1989 Mar; 50(3):385-93. PubMed ID: 2917425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of the ratio of the eighth and ninth components of human complement on complement-lysed membranes.
    Stewart JL; Monahan JB; Brickner A; Sodetz JM
    Biochemistry; 1984 Aug; 23(18):4016-22. PubMed ID: 6487588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biosynthesis of the subcomponents C1q, C1r and C1s of the first component of complement (C1) by guinea pig hepatocyte primary cultures.
    Ramadori G; Heinz HP; Martin H; Meyer zum Büschenfelde KH; Loos M
    Eur J Immunol; 1986 Sep; 16(9):1137-41. PubMed ID: 3019707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation of EAC142 and EAC1423 with macrophage culture supernatant containing the secreted complement components C1 to C3.
    Brade V; Beuscher HU
    Immunobiology; 1984 Mar; 166(2):177-89. PubMed ID: 6724636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9.
    Rollins SA; Zhao J; Ninomiya H; Sims PJ
    J Immunol; 1991 Apr; 146(7):2345-51. PubMed ID: 1706395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human peritoneal macrophages. Production in vitro of the active terminal complement components C5 to C9 and a functional alternative pathway of complement. Brief report.
    Hetland G; Bungum L
    APMIS; 1988 Jan; 96(1):89-92. PubMed ID: 3345254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Number of hits necessary for complement-mediated hemolysis.
    Takeda J; Kozono H; Takata Y; Hong K; Kinoshita T; Sayama K; Tanaka E; Inoue K
    Microbiol Immunol; 1986; 30(5):461-8. PubMed ID: 3747864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hemolytic equivalence of human, guinea pig and canine complement proteins.
    Sargent AU; Johnson SB
    Immunol Commun; 1980; 9(5):453-63. PubMed ID: 6903556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinction between C8-mediated and C8/C9-mediated hemolysis on the basis of independent 86Rb and hemoglobin release.
    Gee AP; Boyle MD; Borsos T
    J Immunol; 1980 Apr; 124(4):1905-10. PubMed ID: 7365242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human alveolar macrophages synthesize the functional alternative pathway of complement and active C5 and C9 in vitro.
    Hetland G; Johnson E; Aasebø U
    Scand J Immunol; 1986 Nov; 24(5):603-8. PubMed ID: 3787189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of therminal components of human complement by a trypsin-activated complex of human factor B and cobra venom factor.
    Miyama A; Kato T; Minoda I; Ueda T; Kashiba S
    Jpn J Microbiol; 1976 Dec; 20(6):507-16. PubMed ID: 1035353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane factors responsible for homologous species restriction of complement-mediated lysis: evidence for a factor other than DAF operating at the stage of C8 and C9.
    Shin ML; Hänsch G; Hu VW; Nicholson-Weller A
    J Immunol; 1986 Mar; 136(5):1777-82. PubMed ID: 2419414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement lysis of human erythrocytes. III. Differing effectiveness of human and guinea pig C9 on normal and paroxysmal nocturnal hemoglobinuria cells.
    Rosenfeld SI; Packman CH; Jenkins DE; Countryman JK; Leddy JP
    J Immunol; 1980 Nov; 125(5):2063-8. PubMed ID: 6776186
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.